Influenza A virus

Last updated

Influenza A virus
Viruses-12-00504-g001.webp
Structure of influenza A virus
Influenza A - late passage.jpg
TEM micrograph of influenza A viruses
Virus classification OOjs UI icon edit-ltr.svg
(unranked): Virus
Realm: Riboviria
Kingdom: Orthornavirae
Phylum: Negarnaviricota
Class: Insthoviricetes
Order: Articulavirales
Family: Orthomyxoviridae
Genus: Alphainfluenzavirus
Species:
Influenza A virus
Subtypes

See text

Influenza A virus (IAV) is a pathogen that causes the flu in birds and some mammals, including humans. [1] It is an RNA virus whose subtypes have been isolated from wild birds. Occasionally, it is transmitted from wild to domestic birds, and this may cause severe disease, outbreaks, or human influenza pandemics. [2] [3] [4]

Contents

Each virus subtype includes a wide variety of strains with differing pathogenic profiles; some may cause disease only in one species but others to multiple ones. Because the viral genome is segmented, subtypes are neither strains nor lineages, as the subtype designation refers to proteins encoded by only two of the eight genome segments.

A filtered and purified influenza A vaccine for humans has been developed and many countries have stockpiled it to allow a quick administration to the population in the event of an avian influenza pandemic. In 2011, researchers reported the discovery of an antibody effective against all types of the influenza A virus. [5]

Classification

Diagram of influenza nomenclature InfluenzaNomenclatureDiagram.svg
Diagram of influenza nomenclature

Influenza A virus is the only species of the genus Alphainfluenzavirus of the virus family Orthomyxoviridae . [6] There are two methods of classification, one based on surface proteins (originally serotypes), [7] and the other based on its behavior, mainly the host animal.

Subtypes

There are two proteins on the surface of the viral envelope: [8]

The hemagglutinin is central to the virus's recognizing and binding to target cells, and also to its then infecting the cell with its RNA. The neuraminidase, on the other hand, is critical for the subsequent release of the daughter virus particles created within the infected cell so they can spread to other cells.[ citation needed ]

Different influenza virus genomes encode different hemagglutinin and neuraminidase proteins. Based on how the different H and N proteins react to antisera, scientists defined 18 types of hemaglutinin and 11 types of neuraminidase. [9] [10] In modern days, determination of serotype is more commonly done by polymerase chain reaction. [11] For example, "H5N1" designates an influenza A subtype that has a type-5 hemagglutinin (H) protein and a type-1 neuraminidase (N) protein. [9] Further variations exist within the subtypes and can lead to very significant differences in the virus's behavior. [lower-alpha 1]

By definition, the subtyping scheme only takes into account the two outer proteins, not the at least 8 proteins internal to the virus. [15]

Host and pathogenicity

Variants are sometimes named according to the species (host) in which the strain is endemic or to which it is adapted. The main variants named using this convention are:[ citation needed ]

Variants have also sometimes been named according to their deadliness in poultry, especially chickens:[ citation needed ]

Individual virus

Using subtyping and host range is not sufficient to uniquely identify an influenza A virus (or a lineage of them sharing a common ancestor). To unambiguously describe a specific collection of viruses, researchers use the Influenza virus nomenclature, which describes, among other things, the serotype, time, and place of collection. Some examples include: [16]

Some variants [lower-alpha 2] are informally identified and named according to the isolate they resemble, thus are presumed to share lineage (example Fujian flu virus-like); according to their typical host (example human flu virus); according to their subtype (example H3N2); and according to their deadliness (example LP, low pathogenic). So a flu from a virus similar to the isolate A/Fujian/411/2002 (H3N2) is called Fujian flu, human flu, and H3N2 flu.[ citation needed ]

Most known strains are extinct strains. For example, the annual flu subtype H3N2 no longer contains the strain that caused the Hong Kong flu, A/Hong Kong/1/1968 (H3N2). The World Health Organization recommends flu shots for the 2023-2024 flu season in northern hemisphere to use the A/Darwin/9/2021 (H3N2)-like virus. [17]

Annual flu

The annual flu (also called "seasonal flu" or "human flu") in the US "results in approximately 36,000 deaths and more than 200,000 hospitalizations each year. In addition to this human toll, influenza is annually responsible for a total cost of over $10 billion in the U.S." [18] Globally the toll of influenza virus is estimated at 290,000–645,000 deaths annually, exceeding previous estimates. [19]

The annually updated, trivalent influenza vaccine consists of hemagglutinin (HA) surface glycoprotein components from influenza H3N2, H1N1, and B influenza viruses. [20]

Measured resistance to the standard antiviral drugs amantadine and rimantadine in H3N2 has increased from 1% in 1994 to 12% in 2003 to 91% in 2005.[ citation needed ]

"Contemporary human H3N2 influenza viruses are now endemic in pigs in southern China and can reassort with avian H5N1 viruses in this intermediate host." [21]

FI6 antibody

FI6, an antibody that targets the hemagglutinin protein, was discovered in 2011. FI6 is the only known antibody effective against all 16 subtypes of the influenza A virus. [22] [23] [24]

Structure and genetics

Influenza A viruses are negative-sense, single-stranded, segmented RNA virus. The several subtypes are labeled according to an H number (for the type of hemagglutinin) and an N number (for the type of neuraminidase). There are 18 different known H antigens (H1 to H18) and 11 different known N antigens (N1 to N11). [9] [10] H17N10 was isolated from fruit bats in 2012. [25] [26] H18N11 was discovered in a Peruvian bat in 2013. [10]

A transmission electron micrograph (TEM) of the reconstructed 1918 pandemic influenza virus. The bottom structure represents membrane debris from the cells used to amplify the virus. Pictured are the 'elliptical' particles representing the smallest particles produced by influenza virus. Purification techniques often deform the particles without proper fixation protocols, leading to 'spherical' appearance. Filamentous or intermediate sized particles simply extend along the long axis on the opposite side of the genome segments. EM of influenza virus.jpg
A transmission electron micrograph (TEM) of the reconstructed 1918 pandemic influenza virus. The bottom structure represents membrane debris from the cells used to amplify the virus. Pictured are the 'elliptical' particles representing the smallest particles produced by influenza virus. Purification techniques often deform the particles without proper fixation protocols, leading to 'spherical' appearance. Filamentous or intermediate sized particles simply extend along the long axis on the opposite side of the genome segments.

Influenza type A viruses are very similar in structure to influenza viruses types B, C, and D. [29] The virus particle (also called the virion) is 80–120 nanometers in diameter such that the smallest virions adopt an elliptical shape. [30] [28] The length of each particle varies considerably, owing to the fact that influenza is pleomorphic, and can be in excess of many tens of micrometers, producing filamentous virions. [31] Confusion about the nature of influenza virus pleomorphy stems from the observation that lab adapted strains typically lose the ability to form filaments [32] and that these lab adapted strains were the first to be visualized by electron microscopy. [33] Despite these varied shapes, the virions of all influenza type A viruses are similar in composition. They are all made up of a viral envelope containing two main types of proteins, wrapped around a central core. [34]

The two large proteins found on the outside of viral particles are hemagglutinin (HA) and neuraminidase (NA). HA is a protein that mediates binding of the virion to target cells and entry of the viral genome into the target cell. NA is involved in release from the abundant non-productive attachment sites present in mucus [35] as well as the release of progeny virions from infected cells. [36] These proteins are usually the targets for antiviral drugs. [37] Furthermore, they are also the antigen proteins to which a host's antibodies can bind and trigger an immune response. Influenza type A viruses are categorized into subtypes based on the type of these two proteins on the surface of the viral envelope. There are 16 subtypes of HA and 9 subtypes of NA known, but only H 1, 2 and 3, and N 1 and 2 are commonly found in humans. [38]

The central core of a virion contains the viral genome and other viral proteins that package and protect the genetic material. Unlike the genomes of most organisms (including humans, animals, plants, and bacteria) which are made up of double-stranded DNA, many viral genomes are made up of a different, single-stranded nucleic acid called RNA. Unusually for a virus, though, the influenza type A virus genome is not a single piece of RNA; instead, it consists of segmented pieces of negative-sense RNA, each piece containing either one or two genes which code for a gene product (protein). [34] The term negative-sense RNA just implies that the RNA genome cannot be translated into protein directly; it must first be transcribed to positive-sense RNA before it can be translated into protein products. The segmented nature of the genome allows for the exchange of entire genes between different viral strains. [34]

Influenza A virus structure Viruses-10-00497-g001.png
Influenza A virus structure

The entire Influenza A virus genome is 13,588 bases long and is contained on eight RNA segments that code for at least 10 but up to 14 proteins, depending on the strain. The relevance or presence of alternate gene products can vary: [15]

Influenza A virus replication cycle Viruses-12-00504-g002.webp
Influenza A virus replication cycle

The RNA segments of the viral genome have complementary base sequences at the terminal ends, allowing them to bond to each other with hydrogen bonds. [36] Transcription of the viral (-) sense genome (vRNA) can only proceed after the PB2 protein binds to host capped RNAs, allowing for the PA subunit to cleave several nucleotides after the cap. This host-derived cap and accompanied nucleotides serve as the primer for viral transcription initiation. Transcription proceeds along the vRNA until a stretch of several uracil bases is reached, initiating a 'stuttering' whereby the nascent viral mRNA is poly-adenylated, producing a mature transcript for nuclear export and translation by host machinery. [40]

The RNA synthesis takes place in the cell nucleus, while the synthesis of proteins takes place in the cytoplasm. Once the viral proteins are assembled into virions, the assembled virions leave the nucleus and migrate towards the cell membrane. [41] The host cell membrane has patches of viral transmembrane proteins (HA, NA, and M2) and an underlying layer of the M1 protein which assist the assembled virions to budding through the membrane, releasing finished enveloped viruses into the extracellular fluid. [41]

The subtypes of influenza A virus are estimated to have diverged 2,000 years ago. Influenza viruses A and B are estimated to have diverged from a single ancestor around 4,000 years ago, while the ancestor of influenza viruses A and B and the ancestor of influenza virus C are estimated to have diverged from a common ancestor around 8,000 years ago. [42]

Multiplicity reactivation

Influenza virus is able to undergo multiplicity reactivation after inactivation by UV radiation, [43] [44] or by ionizing radiation. [45] If any of the eight RNA strands that make up the genome contains damage that prevents replication or expression of an essential gene, the virus is not viable when it alone infects a cell (a single infection). However, when two or more damaged viruses infect the same cell (multiple infection), viable progeny viruses can be produced provided each of the eight genomic segments is present in at least one undamaged copy. That is, multiplicity reactivation can occur.[ citation needed ]

Upon infection, influenza virus induces a host response involving increased production of reactive oxygen species, and this can damage the virus genome. [46] If, under natural conditions, virus survival is ordinarily vulnerable to the challenge of oxidative damage, then multiplicity reactivation is likely selectively advantageous as a kind of genomic repair process. It has been suggested that multiplicity reactivation involving segmented RNA genomes may be similar to the earliest evolved form of sexual interaction in the RNA world that likely preceded the DNA world. [47]

Human influenza virus

Timeline of flu pandemics and epidemics caused by influenza A virus Viruses-10-00497-g004.png
Timeline of flu pandemics and epidemics caused by influenza A virus

"Human influenza virus" usually refers to those subtypes that spread widely among humans. H1N1, H1N2, and H3N2 are the only known influenza A virus subtypes currently circulating among humans. [48]

Genetic factors in distinguishing between "human flu viruses" and "avian influenza viruses" include:

PB2: (RNA polymerase): Amino acid (or residue) position 627 in the PB2 protein encoded by the PB2 RNA gene. Until H5N1, all known avian influenza viruses had a Glu at position 627, while all human influenza viruses had a lysine.
HA: (hemagglutinin): Avian influenza HA binds alpha 2–3 sialic acid receptors, while human influenza HA binds alpha 2–6 sialic acid receptors. Swine influenza viruses have the ability to bind both types of sialic acid receptors.

Human flu symptoms usually include fever, cough, sore throat, muscle aches, conjunctivitis and, in severe cases, breathing problems and pneumonia that may be fatal. The severity of the infection will depend in large part on the state of the infected person's immune system and if the victim has been exposed to the strain before, and is therefore partially immune. Follow-up studies on the impact of statins on influenza virus replication show that pre-treatment of cells with atorvastatin suppresses virus growth in culture. [49]

Highly pathogenic H5N1 avian influenza in a human is far worse, killing 50% of humans who catch it. In one case, a boy with H5N1 experienced diarrhea followed rapidly by a coma without developing respiratory or flu-like symptoms. [50]

The influenza A virus subtypes that have been confirmed in humans, ordered by the number of known human pandemic deaths, are:

H1N1
Human cases and fatalities caused by different influenza A virus subtypes Viruses-10-00497-g005.png
Human cases and fatalities caused by different influenza A virus subtypes
H1N1 was responsible for the 2009 pandemic in both human and pig populations. A variant of H1N1 was responsible for the Spanish flu pandemic that killed some 50 million to 100 million people worldwide over about a year in 1918 and 1919. [56] Another variant was named a pandemic threat in the 2009 flu pandemic. Controversy arose in October 2005, after the H1N1 genome was published in the journal, Science, because of fears that this information could be used for bioterrorism. [57]
H1N2
H1N2 is endemic in pig populations [58] and has been documented in a few human cases. [55]
H2N2
The Asian flu, a pandemic outbreak of H2N2 avian influenza, originated in China in 1957, spread worldwide that same year during which an influenza vaccine was developed, lasted until 1958 and caused between one and four million deaths.[ citation needed ]
H3N2
H3N2 is currently[ when? ] endemic in both human and pig populations. It evolved from H2N2 by antigenic shift and caused the Hong Kong flu pandemic of 1968, and 1969, that killed up to 750,000. [59] A severe form of the H3N2 virus killed several children in the United States in late 2003. [60]
The dominant strain of annual flu in January 2006 was H3N2. Measured resistance to the standard antiviral drugs amantadine and rimantadine in H3N2 increased from 1% in 1994 to 12% in 2003 to 91% in 2005. [61] Human H3N2 influenza viruses are now[ when? ] endemic in pigs in southern China, where they circulate together with avian H5N1 viruses. [21]
H5N1
H5N1 is the world's major influenza pandemic threat.[ clarification needed ][ citation needed ]
H5N2
Japan's Health Ministry said January 2006 that poultry farm workers in Ibaraki prefecture may have been exposed to H5N2 in 2005. [62] The H5N2 antibody titers of paired sera of 13 subjects increased fourfold or more. [63]
H5N8
In February 2021, Russia reported the first known cases of H5N8 in humans. Seven people were confirmed to have been infected in December 2020 and have since recovered. [64] There was no indication of human-to-human transmission. [65]
H5N9

A highly pathogenic strain of H5N9 caused a minor flu outbreak in 1966 in Ontario and Manitoba, Canada in turkeys. [66]
H7N2
One person in New York in 2003, and one person in Virginia in 2002, were found to have serologic evidence of infection with H7N2.[ citation needed ] Both fully recovered. [67] [ failed verification ]
H7N3
In North America, the presence of avian influenza strain H7N3 was confirmed at several poultry farms in British Columbia in February 2004. As of April 2004, 18 farms had been quarantined to halt the spread of the virus. Two cases of humans with avian influenza have been confirmed in that region. "Symptoms included conjunctivitis and mild influenza-like illness." [68] Both fully recovered.
H7N7
H7N7 has unusual zoonotic potential. In 2003 in the Netherlands, 89 people were confirmed to have H7N7 influenza virus infection following an outbreak in poultry on several farms. One death was recorded.
H7N9
On 2 April 2013, the Centre for Health Protection (CHP) of the Department of Health of Hong Kong confirmed four more cases in Jiangsu province in addition to the three cases initially reported on 31 March 2013. [69] This virus also has the greatest potential for an influenza pandemic among all of the Influenza A subtypes. [70]
H9N2
Low pathogenic avian influenza A (H9N2) infection was confirmed in 1999, in China and Hong Kong in two children, and in 2003 in Hong Kong in one child. All three fully recovered. [67] [ failed verification ]
H10N7
In 2004, in Egypt, H10N7 was reported for the first time in humans. It caused illness in two infants in Egypt. One child’s father was a poultry merchant. [71]

H10N3

In May 2021, in Zhenjiang, China H10N3 was reported for the first time in humans. One person was infected. [72]

Evolution

Genetic evolution of human and swine influenza viruses, 1918-2009 Genetic Relationships Among Human and Swine Influenza Viruses, 1918-2009 (7704014350).jpg
Genetic evolution of human and swine influenza viruses, 1918–2009

According to Jeffery Taubenberger: [73]

All influenza A pandemics since [the Spanish flu pandemic], and indeed almost all cases of influenza A worldwide (excepting human infections from avian viruses such as H5N1 and H7N7), have been caused by descendants of the 1918 virus, including "drifted" H1N1 viruses and reassorted H2N2 and H3N2 viruses. The latter are composed of key genes from the 1918 virus, updated by subsequently incorporated avian influenza genes that code for novel surface proteins, making the 1918 virus indeed the "mother" of all pandemics.

Researchers from the National Institutes of Health used data from the Influenza Genome Sequencing Project and concluded that during the ten-year period examined, most of the time the hemagglutinin gene in H3N2 showed no significant excess of mutations in the antigenic regions while an increasing variety of strains accumulated. This resulted in one of the variants eventually achieving higher fitness, becoming dominant, and in a brief interval of rapid evolution, rapidly sweeping through the population and eliminating most other variants. [74]

In the short-term evolution of influenza A virus, a 2006 study found that stochastic, or random, processes are key factors. [75] Influenza A virus HA antigenic evolution appears to be characterized more by punctuated, sporadic jumps as opposed to a constant rate of antigenic change. [76] Using phylogenetic analysis of 413 complete genomes of human influenza A viruses that were collected throughout the state of New York, the authors of Nelson et al. 2006 were able to show that genetic diversity, and not antigenic drift, shaped the short-term evolution of influenza A via random migration and reassortment. The evolution of these viruses is dominated more by the random importation of genetically different viral strains from other geographic locations and less by natural selection. Within a given season, adaptive evolution is infrequent and had an overall weak effect as evidenced from the data gathered from the 413 genomes. Phylogenetic analysis revealed the different strains were derived from newly imported genetic material as opposed to isolates that had been circulating in New York in previous seasons. Therefore, the gene flow in and out of this population, and not natural selection, was more important in the short term.[ citation needed ]

Other animals

See H5N1 for the current[ when? ] epizootic (an epidemic in nonhumans) and panzootic (a disease affecting animals of many species especially over a wide area) of H5N1 influenza

Avian influenza

Fowl act as natural asymptomatic carriers of influenza A viruses. Prior to the current[ when? ] H5N1 epizootic, strains of influenza A virus had been demonstrated to be transmitted from wildfowl to only birds, pigs, horses, seals, whales and humans; and only between humans and pigs and between humans and domestic fowl; and not other pathways such as domestic fowl to horse. [77]

Wild aquatic birds are the natural hosts for a large variety of influenza A viruses. Occasionally, viruses are transmitted from these birds to other species and may then cause devastating outbreaks in domestic poultry or give rise to human influenza pandemics. [3] [4]

H5N1 has been shown to be transmitted to tigers, leopards, and domestic cats that were fed uncooked domestic fowl (chickens) with the virus. H3N8 viruses from horses have crossed over and caused outbreaks in dogs. Laboratory mice have been infected successfully with a variety of avian flu genotypes. [78]

Influenza A viruses spread in the air and in manure, and survives longer in cold weather. They can also be transmitted by contaminated feed, water, equipment, and clothing; however, there is no evidence the virus can survive in well-cooked meat. Symptoms in animals vary, but virulent strains can cause death within a few days. Avian influenza viruses that the World Organisation for Animal Health and others test for to control poultry disease include H5N1, H7N2, H1N7, H7N3, H13N6, H5N9, H11N6, H3N8, H9N2, H5N2, H4N8, H10N7, H2N2, H8N4, H14N5, H6N5, and H12N5.[ citation needed ]

Known outbreaks of highly pathogenic flu in poultry 1959–2003 [79]
YearAreaAffectedSubtype
1959ScotlandChicken H5N1
1963EnglandTurkey H7N3
1966Ontario (Canada)Turkey H5N9
1976Victoria (Australia)Chicken H7N7
1979GermanyChickenH7N7
1979EnglandTurkeyH7N7
1983Pennsylvania (US)*Chicken, turkey H5N2
1983IrelandTurkey H5N8
1985Victoria (Australia)ChickenH7N7
1991EnglandTurkeyH5N1
1992Victoria (Australia)ChickenH7N3
1994Queensland (Australia)ChickenH7N3
1994Mexico*ChickenH5N2
1994Pakistan*ChickenH7N3
1997New South Wales (Australia)Chicken H7N4
1997Hong Kong (China)*ChickenH5N1
1997ItalyChickenH5N2
1999Italy*Turkey H7N1
2002Hong Kong (China)ChickenH5N1
2002ChileChickenH7N3
2003Netherlands*ChickenH7N7

*Outbreaks with significant spread to numerous farms, resulting in great economic losses. Most other outbreaks involved little or no spread from the initially infected farms.

More than 400 harbor seal deaths were recorded in New England between December 1979 and October 1980, from acute pneumonia caused by the influenza virus, A/Seal/Mass/1/180 (H7N7). [80]

Swine flu

Swine influenza (or "pig influenza") refers to a subset of Orthomyxoviridae that create influenza and are endemic in pigs. The species of Orthomyxoviridae that can cause flu in pigs are influenza A virus and influenza C virus, but not all genotypes of these two species infect pigs. The known subtypes of influenza A virus that create influenza and are endemic in pigs are H1N1, H1N2, H3N1 and H3N2. In 1997, H3N2 viruses from humans entered the pig population, causing widespread disease among pigs. [81]

Horse flu

Horse flu (or "equine influenza") refers to varieties of influenza A virus that affect horses. Horse flu viruses were only isolated in 1956. The two main types of virus are called equine-1 (H7N7), which commonly affects horse heart muscle, and equine-2 (H3N8), which is usually more severe. H3N8 viruses from horses have infected dogs. [81]

Dog flu

Dog flu (or "canine influenza") refers to varieties of influenza A virus that affect dogs. The equine influenza virus H3N8 was found to infect and kill – with respiratory illness – greyhound race dogs at a Florida racetrack in January 2004.

Bat flu

Bat flu (or "Bat influenza") refers to the H17N10 and H18N11 influenza A virus strains that were discovered in Central and South American fruit bats as well as a H9N2 virus isolated from the Egyptian fruit bat. [82] Until now it is unclear whether these bat-derived viruses are circulating in any non-bat species and whether they pose a zoonotic threat. Initial characterization of the H18N11 subtype, however, suggests that this bat influenza virus is not well adapted to any other species than bats. [83]

H3N8

H3N8 is now endemic in birds, horses and dogs.

Subtype list

Influenza A virus has the following subtypes:[ citation needed ]

See also

Notes

  1. ↑ For example:
    • Swapping the H gene in a HPAI-H5N8 with the H gene in a LPAI-H5N8 generates a H5N8 virus with low virulence. [12]
    • The human immune system does not very effectively recognize new types of H3N2 viruses despite having seen another H3N2 before. As a result, each year's flu vaccine is reformulated according to a list of likely strains from the WHO. [13] The same occurs in chickens: H5 vaccines that target non-2.3.4.4b H5 genes do not effectively protect against the 2.3.4.4b branch of H5. [14]
  2. ↑ "virus", "variant", and "strain" all refer to levels finer than the subtype.

Related Research Articles

<span class="mw-page-title-main">Antigenic shift</span> Process by which two or more different strains of a virus combine to form a new subtype

Antigenic shift is the process by which two or more different strains of a virus, or strains of two or more different viruses, combine to form a new subtype having a mixture of the surface antigens of the two or more original strains. The term is often applied specifically to influenza, as that is the best-known example, but the process is also known to occur with other viruses, such as visna virus in sheep. Antigenic shift is a specific case of reassortment or viral shift that confers a phenotypic change.

<span class="mw-page-title-main">Hemagglutinin (influenza)</span> Hemagglutinin of influenza virus

Influenza hemagglutinin (HA) or haemagglutinin[p] is a homotrimeric glycoprotein found on the surface of influenza viruses and is integral to its infectivity.

<i>Orthomyxoviridae</i> Family of RNA viruses including the influenza viruses

Orthomyxoviridae is a family of negative-sense RNA viruses. It includes seven genera: Alphainfluenzavirus, Betainfluenzavirus, Gammainfluenzavirus, Deltainfluenzavirus, Isavirus, Thogotovirus, and Quaranjavirus. The first four genera contain viruses that cause influenza in birds and mammals, including humans. Isaviruses infect salmon; the thogotoviruses are arboviruses, infecting vertebrates and invertebrates. The Quaranjaviruses are also arboviruses, infecting vertebrates (birds) and invertebrates (arthropods).

Antigenic drift is a kind of genetic variation in viruses, arising from the accumulation of mutations in the virus genes that code for virus-surface proteins that host antibodies recognize. This results in a new strain of virus particles that is not effectively inhibited by the antibodies that prevented infection by previous strains. This makes it easier for the changed virus to spread throughout a partially immune population. Antigenic drift occurs in both influenza A and influenza B viruses.

<span class="mw-page-title-main">Influenza A virus subtype H5N1</span> Subtype of influenza A virus

Influenza A virus subtype H5N1 (A/H5N1) is a subtype of the influenza A virus which can cause illness in humans and many other species. A bird-adapted strain of H5N1, called HPAI A(H5N1) for highly pathogenic avian influenza virus of type A of subtype H5N1, is the highly pathogenic causative agent of H5N1 flu, commonly known as avian influenza. It is enzootic in many bird populations, especially in Southeast Asia. One strain of HPAI A(H5N1) is spreading globally after first appearing in Asia. It is epizootic and panzootic, killing tens of millions of birds and spurring the culling of hundreds of millions of others to stem its spread. Many references to "bird flu" and H5N1 in the popular media refer to this strain.

<span class="mw-page-title-main">Swine influenza</span> Infection caused by influenza viruses endemic to pigs

Swine influenza is an infection caused by any of several types of swine influenza viruses. Swine influenza virus (SIV) or swine-origin influenza virus (S-OIV) refers to any strain of the influenza family of viruses that is endemic in pigs. As of 2009, identified SIV strains include influenza C and the subtypes of influenza A known as H1N1, H1N2, H2N1, H3N1, H3N2, and H2N3.

<span class="mw-page-title-main">Influenza pandemic</span> Pandemic involving influenza

An influenza pandemic is an epidemic of an influenza virus that spreads across a large region and infects a large proportion of the population. There have been six major influenza epidemics in the last 140 years, with the 1918 flu pandemic being the most severe; this is estimated to have been responsible for the deaths of 50–100 million people. The 2009 swine flu pandemic resulted in under 300,000 deaths and is considered relatively mild. These pandemics occur irregularly.

<span class="mw-page-title-main">Influenza A virus subtype H2N2</span> Subtype of Influenza A virus

Influenza A virus subtype H2N2 (A/H2N2) is a subtype of Influenza A virus. H2N2 has mutated into various strains including the "Asian flu" strain, H3N2, and various strains found in birds. It is also suspected of causing a human pandemic in 1889. The geographic spreading of the 1889 Russian flu has been studied and published.

<span class="mw-page-title-main">Influenza A virus subtype H3N2</span> Virus subtype

Influenza A virus subtype H3N2 (A/H3N2) is a subtype of viruses that causes influenza (flu). H3N2 viruses can infect birds and mammals. In birds, humans, and pigs, the virus has mutated into many strains. In years in which H3N2 is the predominant strain, there are more hospitalizations.

<i>Influenza B virus</i> Species of virus

Influenza B virus is the only species in the genus Betainfluenzavirus in the virus family Orthomyxoviridae.

<span class="mw-page-title-main">Influenza A virus subtype H1N2</span> Virus subtype

Influenza A virus subtype H1N2 (A/H1N2) is a subtype of the species Influenza A virus. It is currently endemic in pig populations and is occasionally seen in humans.

<span class="mw-page-title-main">H5N1 genetic structure</span>

H5N1 genetic structure is the molecular structure of the H5N1 virus's RNA.

<span class="mw-page-title-main">Spanish flu research</span> Scientific research of the 1918 influenza pandemic

Spanish flu research concerns studies regarding the causes and characteristics of the Spanish flu, a variety of influenza that in 1918 was responsible for the worst influenza pandemic in modern history. Many theories about the origins and progress of the Spanish flu persisted in the literature, but it was not until 2005, when various samples of lung tissue were recovered from American World War I soldiers and from an Inupiat woman buried in permafrost in a mass grave in Brevig Mission, Alaska, that significant genetic research was made possible.

<span class="mw-page-title-main">Fujian flu</span> Strains of influenza

Fujian flu refers to flu caused by either a Fujian human flu strain of the H3N2 subtype of the Influenza A virus or a Fujian bird flu strain of the H5N1 subtype of the Influenza A virus. These strains are named after Fujian, a coastal province in Southeast China.

<span class="mw-page-title-main">Influenza</span> Infectious disease

Influenza, commonly known as "the flu" or just "flu", is an infectious disease caused by influenza viruses. Symptoms range from mild to severe and often include fever, runny nose, sore throat, muscle pain, headache, coughing, and fatigue. These symptoms begin from one to four days after exposure to the virus and last for about 2–8 days. Diarrhea and vomiting can occur, particularly in children. Influenza may progress to pneumonia, which can be caused by the virus or by a subsequent bacterial infection. Other complications of infection include acute respiratory distress syndrome, meningitis, encephalitis, and worsening of pre-existing health problems such as asthma and cardiovascular disease.

<span class="mw-page-title-main">Viral neuraminidase</span> InterPro Family

Viral neuraminidase is a type of neuraminidase found on the surface of influenza viruses that enables the virus to be released from the host cell. Neuraminidases are enzymes that cleave sialic acid groups from glycoproteins. Viral neuraminidase was discovered by Alfred Gottschalk at the Walter and Eliza Hall Institute in 1957. Neuraminidase inhibitors are antiviral agents that inhibit influenza viral neuraminidase activity and are of major importance in the control of influenza.

The FluChip is a low-density DNA microarray for the identification of influenza viruses, originally developed at the University of Colorado at Boulder in the laboratory of Professor Kathy Rowlen in collaboration with the Centers for Disease Control and Prevention (CDC) in Atlanta.

<span class="mw-page-title-main">H5N1 vaccine</span> Vaccine designed to provide immunity against H5N1 influenza

A H5N1 vaccine is an influenza vaccine intended to provide immunization to influenza A virus subtype H5N1.

<span class="mw-page-title-main">Universal flu vaccine</span> Vaccine that prevents infection from all strains of the flu

A universal flu vaccine is a flu vaccine that is effective against all influenza strains regardless of the virus sub type, antigenic drift or antigenic shift. Hence it should not require modification from year to year. As of 2021 no universal flu vaccine had been approved for general use, several were in development, and one was in clinical trial.

Type A influenza vaccine is for the prevention of infection of influenza A virus and also the influenza-related complications. Different monovalent type A influenza vaccines have been developed for different subtypes of influenza A virus including H1N1 and H5N1. Both intramuscular injection or intranasal spray are available on market. Unlike the seasonal influenza vaccines which are used annually, they are usually used during the outbreak of certain strand of subtypes of influenza A. Common adverse effects includes injection site reaction and local tenderness. Incidences of headache and myalgia were also reported with H1N1 whereas cases of fever has also been demonstrated with H5N1 vaccines. It is stated that immunosuppressant therapies would reduce the therapeutic effects of vaccines and that people with egg allergy should go for the egg-free preparations.

References

  1. ↑ Havers FP, Campbell AJ (2020). "285. Influenza viruses". In Kliegman RM, St Geme III JW (eds.). Nelson Textbook of Pediatrics (21st ed.). Philadelphia: Elsevier. pp. 1727–1739. ISBN   978-0-323-56890-6.
  2. ↑ "Avian influenza (" bird flu") – Fact sheet". WHO.
  3. 1 2 Klenk HD, Matrosovich M, Stech J (2008). "Avian Influenza: Molecular Mechanisms of Pathogenesis and Host Range". In Mettenleiter TC, Sobrino F (eds.). Animal Viruses: Molecular Biology. Caister Academic Press. ISBN   978-1-904455-22-6.
  4. 1 2 Kawaoka Y, ed. (2006). Influenza Virology: Current Topics. Caister Academic Press. ISBN   978-1-904455-06-6.
  5. ↑ Gallagher J (29 July 2011). "'Super antibody' fights off flu". BBC News. Retrieved 29 July 2011.
  6. ↑ "Taxonomy". International Committee on Taxonomy of Viruses (ICTV). Retrieved 19 July 2018.
  7. ↑ Masurel N (1969). "Serological characteristics of a "new" serotype of influenza A virus: the Hong Kong strain". Bulletin of the World Health Organization. 41 (3): 461–8. PMC   2427714 . PMID   5309456.
  8. ↑ Johnson J, Higgins A, Navarro A, Huang Y, Esper FL, Barton N, Esch D, Shaw C, Olivo PD, Miao LY (February 2012). "Subtyping influenza A virus with monoclonal antibodies and an indirect immunofluorescence assay". Journal of Clinical Microbiology. 50 (2): 396–400. doi:10.1128/JCM.01237-11. PMC   3264186 . PMID   22075584.
  9. 1 2 3 "Influenza Type A Viruses and Subtypes". Centers for Disease Control and Prevention. 2 April 2013. Retrieved 13 June 2013.
  10. 1 2 3 Tong S, Zhu X, Li Y, Shi M, Zhang J, Bourgeois M, Yang H, Chen X, Recuenco S, Gomez J, Chen LM, Johnson A, Tao Y, Dreyfus C, Yu W, McBride R, Carney PJ, Gilbert AT, Chang J, Guo Z, Davis CT, Paulson JC, Stevens J, Rupprecht CE, Holmes EC, Wilson IA, Donis RO (October 2013). "New world bats harbor diverse influenza A viruses". PLOS Pathogens. 9 (10): e1003657. doi: 10.1371/journal.ppat.1003657 . PMC   3794996 . PMID   24130481.
  11. ↑ Yang HH, Huang IT, Wu RC, Chen LK (2023). "A highly efficient and accurate method of detecting and subtyping Influenza A pdm H1N1 and H3N2 viruses with newly emerging mutations in the matrix gene in Eastern Taiwan". PLOS ONE. 18 (3): e0283074. Bibcode:2023PLoSO..1883074Y. doi: 10.1371/journal.pone.0283074 . PMC   10035893 . PMID   36952488.
  12. ↑ Scheibner D, Breithaupt A, Luttermann C, Blaurock C, Mettenleiter TC, Abdelwhab EM (13 July 2022). "Genetic Determinants for Virulence and Transmission of the Panzootic Avian Influenza Virus H5N8 Clade 2.3.4.4 in Pekin Ducks". Journal of Virology. 96 (13): e0014922. doi:10.1128/jvi.00149-22. PMC   9278104 . PMID   35670594.
  13. ↑ "Global Influenza Surveillance and Response System (GISRS)". World Health Organization. Archived from the original on 3 October 2011. Retrieved 22 October 2019.
  14. ↑ Tian J, Bai X, Li M, Zeng X, Xu J, Li P, Wang M, Song X, Zhao Z, Tian G, Liu L, Guan Y, Li Y, Chen H (July 2023). "Highly Pathogenic Avian Influenza Virus (H5N1) Clade 2.3.4.4b Introduced by Wild Birds, China, 2021". Emerging Infectious Diseases. 29 (7): 1367–1375. doi: 10.3201/eid2907.221149 . PMC   10310395 . PMID   37347504.
  15. 1 2 Eisfeld AJ, Neumann G, Kawaoka Y (January 2015). "At the centre: influenza A virus ribonucleoproteins". Nature Reviews. Microbiology. 13 (1): 28–41. doi:10.1038/nrmicro3367. PMC   5619696 . PMID   25417656.
  16. 1 2 3 4 Pan American Health Organization (22 November 2022). "Technical Note Influenza Virus Nomenclature".
  17. ↑ "Recommended composition of influenza virus vaccines for use in the 2023-2024 northern hemisphere influenza season". World Health Organization (WHO). 24 February 2023. Archived from the original on 8 March 2023. Retrieved 17 March 2023.
  18. ↑ whitehouse.gov Archived 21 February 2009 at the Wayback Machine National Strategy for Pandemic Influenza – Introduction – "Although remarkable advances have been made in science and medicine during the past century, we are constantly reminded that we live in a universe of microbes – viruses, bacteria, protozoa and fungi that are forever changing and adapting themselves to the human host and the defenses that humans create. Influenza viruses are notable for their resilience and adaptability. While science has been able to develop highly effective vaccines and treatments for many infectious diseases that threaten public health, acquiring these tools is an ongoing challenge with the influenza virus. Changes in the genetic makeup of the virus require us to develop new vaccines on an annual basis and forecast which strains are likely to predominate. As a result, and despite annual vaccinations, the US faces a burden of influenza that results in approximately 36,000 deaths and more than 200,000 hospitalizations each year. In addition to this human toll, influenza is annually responsible for a total cost of over $10 billion in the US. A pandemic, or worldwide outbreak of a new influenza virus, could dwarf this impact by overwhelming our health and medical capabilities, potentially resulting in hundreds of thousands of deaths, millions of hospitalizations, and hundreds of billions of dollars in direct and indirect costs. This Strategy will guide our preparedness and response activities to mitigate that impact."
  19. ↑ Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, Cohen C, Gran JM, Schanzer D, Cowling BJ, Wu P, Kyncl J, Ang LW, Park M, Redlberger-Fritz M, Yu H, Espenhain L, Krishnan A, Emukule G, van Asten L, Pereira da Silva S, Aungkulanon S, Buchholz U, Widdowson MA, Bresee JS (March 2018). "Estimates of global seasonal influenza-associated respiratory mortality: a modelling study". Lancet. 391 (10127): 1285–1300. doi:10.1016/s0140-6736(17)33293-2. PMC   5935243 . PMID   29248255.
  20. ↑ Daum LT, Shaw MW, Klimov AI, Canas LC, Macias EA, Niemeyer D, Chambers JP, Renthal R, Shrestha SK, Acharya RP, Huzdar SP, Rimal N, Myint KS, Gould P (August 2005). "Influenza A (H3N2) outbreak, Nepal". Emerging Infectious Diseases. 11 (8): 1186–91. doi:10.3201/eid1108.050302. PMC   3320503 . PMID   16102305.
    "The 2003–2004 influenza season was severe in terms of its impact on illness because of widespread circulation of antigenically distinct influenza A (H3N2) Fujian-like viruses. These viruses first appeared late during the 2002–2003 influenza season and continued to persist as the dominant circulating strain throughout the subsequent 2003–2004 influenza season, replacing the A/Panama/2007/99-like H3N2 viruses (1). Of the 172 H3N2 viruses genetically characterized by the Department of Defense in 2003–2004, only one isolate (from Thailand) belonged to the A/Panama-like lineage. In February 2003, the World Health Organization (WHO) changed the H3N2 component for the 2004–2005 influenza vaccine to afford protection against the widespread emergence of Fujian-like viruses (2). The annually updated trivalent vaccine consists of hemagglutinin (HA) surface glycoprotein components from influenza H3N2, H1N1, and B viruses."
  21. 1 2 Mahmoud 2005 , p.  126
    "H5N1 virus is now endemic in poultry in Asia (Table 2-1) and has gained an entrenched ecological niche from which to present a long-term pandemic threat to humans. At present, these viruses are poorly transmitted from poultry to humans, and there is no conclusive evidence of human-to-human transmission. However, continued, extensive exposure of the human population to H5N1 viruses increases the likelihood that the viruses will acquire the necessary characteristics for efficient human-to-human transmission through genetic mutation or reassortment with a prevailing human influenza A virus. Furthermore, contemporary human H3N2 influenza viruses are now endemic in pigs in southern China (Peiris et al., 2001) and can reassort with avian H5N1 viruses in this 'intermediate host.' Therefore, it is imperative that outbreaks of H5N1 disease in poultry in Asia are rapidly and sustainably controlled. The seasonality of the disease in poultry, together with the control measures already implemented, are likely to reduce temporarily the frequency of H5N1 influenza outbreaks and the probability of human infection."
  22. ↑ Gallagher J (29 July 2011). "'Super antibody' fights off flu". BBC News.
  23. ↑ "Scientists hail the prospect of a universal vaccine for flu". Independent.co.uk . 29 July 2011.
  24. ↑ Chan AL (28 July 2011). "Universal Flu Vaccine on the Horizon: Researchers Find 'Super Antibody'". HuffPost.
  25. ↑ "Unique new flu virus found in bats". NHS Choices. 1 March 2012. Archived from the original on 8 August 2020. Retrieved 16 May 2012.
  26. ↑ Tong S, Li Y, Rivailler P, Conrardy C, Castillo DA, Chen LM, Recuenco S, Ellison JA, Davis CT, York IA, Turmelle AS, Moran D, Rogers S, Shi M, Tao Y, Weil MR, Tang K, Rowe LA, Sammons S, Xu X, Frace M, Lindblade KA, Cox NJ, Anderson LJ, Rupprecht CE, Donis RO (March 2012). "A distinct lineage of influenza A virus from bats". Proceedings of the National Academy of Sciences of the United States of America. 109 (11): 4269–74. Bibcode:2012PNAS..109.4269T. doi: 10.1073/pnas.1116200109 . PMC   3306675 . PMID   22371588.
  27. ↑ "Details – Public Health Image Library(PHIL)". phil.cdc.gov. Retrieved 24 April 2018.
  28. 1 2 Sugita Y, Noda T, Sagara H, Kawaoka Y (November 2011). "Ultracentrifugation deforms unfixed influenza A virions". The Journal of General Virology. 92 (Pt 11): 2485–93. doi:10.1099/vir.0.036715-0. PMC   3352361 . PMID   21795472.
  29. ↑ Nakatsu S, Murakami S, Shindo K, Horimoto T, Sagara H, Noda T, Kawaoka Y (March 2018). "Influenza C and D Viruses Package Eight Organized Ribonucleoprotein Complexes". Journal of Virology. 92 (6): e02084–17. doi:10.1128/jvi.02084-17. PMC   5827381 . PMID   29321324.
  30. ↑ Noda T (2011). "Native morphology of influenza virions". Frontiers in Microbiology. 2: 269. doi: 10.3389/fmicb.2011.00269 . PMC   3249889 . PMID   22291683.
  31. ↑ Dadonaite B, Vijayakrishnan S, Fodor E, Bhella D, Hutchinson EC (August 2016). "Filamentous influenza viruses". The Journal of General Virology. 97 (8): 1755–64. doi:10.1099/jgv.0.000535. PMC   5935222 . PMID   27365089.
  32. ↑ Seladi-Schulman J, Steel J, Lowen AC (December 2013). "Spherical influenza viruses have a fitness advantage in embryonated eggs, while filament-producing strains are selected in vivo". Journal of Virology. 87 (24): 13343–53. doi:10.1128/JVI.02004-13. PMC   3838284 . PMID   24089563.
  33. ↑ Mosley VM, Wyckoff RW (March 1946). "Electron micrography of the virus of influenza". Nature. 157 (3983): 263. Bibcode:1946Natur.157..263M. doi: 10.1038/157263a0 . PMID   21016866. S2CID   6478026.
  34. 1 2 3 Bouvier NM, Palese P (September 2008). "The biology of influenza viruses". Vaccine. 26 (Suppl 4): D49–53. doi:10.1016/j.vaccine.2008.07.039. PMC   3074182 . PMID   19230160.
  35. ↑ Cohen M, Zhang XQ, Senaati HP, Chen HW, Varki NM, Schooley RT, Gagneux P (November 2013). "Influenza A penetrates host mucus by cleaving sialic acids with neuraminidase". Virology Journal. 10: 321. doi: 10.1186/1743-422x-10-321 . PMC   3842836 . PMID   24261589.
  36. 1 2 Suzuki Y (March 2005). "Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses". Biological & Pharmaceutical Bulletin. 28 (3): 399–408. doi: 10.1248/bpb.28.399 . PMID   15744059.
  37. ↑ Wilson JC, von Itzstein M (July 2003). "Recent strategies in the search for new anti-influenza therapies". Current Drug Targets. 4 (5): 389–408. doi:10.2174/1389450033491019. PMID   12816348.
  38. ↑ Lynch JP, Walsh EE (April 2007). "Influenza: evolving strategies in treatment and prevention". Seminars in Respiratory and Critical Care Medicine. 28 (2): 144–58. doi:10.1055/s-2007-976487. PMID   17458769. S2CID   260316848.
  39. ↑ Khaperskyy DA, Schmaling S, Larkins-Ford J, McCormick C, Gaglia MM (February 2016). "Selective Degradation of Host RNA Polymerase II Transcripts by Influenza A Virus PA-X Host Shutoff Protein". PLOS Pathogens. 12 (2): e1005427. doi: 10.1371/journal.ppat.1005427 . PMC   4744033 . PMID   26849127.
  40. ↑ Te Velthuis AJ, Fodor E (August 2016). "Influenza virus RNA polymerase: insights into the mechanisms of viral RNA synthesis". Nature Reviews. Microbiology. 14 (8): 479–93. doi:10.1038/nrmicro.2016.87. PMC   4966622 . PMID   27396566.
  41. 1 2 Smith AE, Helenius A (April 2004). "How viruses enter animal cells". Science. 304 (5668): 237–42. Bibcode:2004Sci...304..237S. doi:10.1126/science.1094823. PMID   15073366. S2CID   43062708.
  42. ↑ Yoshiyuki Suzuki, Masatoshi Nei (1 April 2001). "Origin and Evolution of Influenza Virus Hemagglutinin Genes". Molecular Biology and Evolution . 19 (4). Ocford Academic: 501–509. doi: 10.1093/oxfordjournals.molbev.a004105 . PMID   11919291.
  43. ↑ Barry RD (August 1961). "The multiplication of influenza virus. II. Multiplicity reactivation of ultraviolet irradiated virus". Virology. 14 (4): 398–405. doi:10.1016/0042-6822(61)90330-0. hdl: 1885/109240 . PMID   13687359.
  44. ↑ Henle W, Liu OC (October 1951). "Studies on host-virus interactions in the chick embryo-influenza virus system. VI. Evidence for multiplicity reactivation of inactivated virus". The Journal of Experimental Medicine. 94 (4): 305–22. doi:10.1084/jem.94.4.305. PMC   2136114 . PMID   14888814.
  45. ↑ Gilker JC, Pavilanis V, Ghys R (June 1967). "Multiplicity reactivation in gamma irradiated influenza viruses". Nature. 214 (5094): 1235–7. Bibcode:1967Natur.214.1235G. doi:10.1038/2141235a0. PMID   6066111. S2CID   4200194.
  46. ↑ Peterhans E (May 1997). "Oxidants and antioxidants in viral diseases: disease mechanisms and metabolic regulation". The Journal of Nutrition. 127 (5 Suppl): 962S–965S. doi: 10.1093/jn/127.5.962S . PMID   9164274.
  47. ↑ Bernstein H, Byerly HC, Hopf FA, Michod RE (October 1984). "Origin of sex". Journal of Theoretical Biology. 110 (3): 323–51. Bibcode:1984JThBi.110..323B. doi:10.1016/S0022-5193(84)80178-2. PMID   6209512.
  48. ↑ CDC Key Facts About Avian Influenza (Bird Flu) and Avian Influenza A (H5N1) Virus
  49. ↑ Episcopio D, Aminov S, Benjamin S, Germain G, Datan E, Landazuri J, Lockshin RA, Zakeri Z (April 2019). "Atorvastatin restricts the ability of influenza virus to generate lipid droplets and severely suppresses the replication of the virus". The FASEB Journal. 33 (8): 9516–9525. doi: 10.1096/fj.201900428RR . PMC   6662987 . PMID   31125254.
  50. ↑ de Jong MD, Bach VC, Phan TQ, Vo MH, Tran TT, Nguyen BH, Beld M, Le TP, Truong HK, Nguyen VV, Tran TH, Do QH, Farrar J (February 2005). "Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma". The New England Journal of Medicine. 352 (7): 686–91. doi: 10.1056/NEJMoa044307 . PMID   15716562. S2CID   17703507.
  51. ↑ "New bird flu strain in China "one of the most lethal" warns WHO". MercoPress. Retrieved 6 December 2020.
  52. ↑ "The next pandemic and how to head it off: eat a plant-based diet". South China Morning Post. 19 October 2020. Retrieved 6 December 2020.
  53. ↑ "Making the leap". News. 677 Huntington Avenue, Boston, Ma 02115 +1495‑1000. 24 October 2013. Retrieved 6 December 2020.
  54. ↑ Ungchusak K, Auewarakul P, Dowell SF, Kitphati R, Auwanit W, Puthavathana P, Uiprasertkul M, Boonnak K, Pittayawonganon C, Cox NJ, Zaki SR (27 January 2005). "Probable Person-to-Person Transmission of Avian Influenza A (H5N1)". New England Journal of Medicine. 352 (4): 333–340. doi: 10.1056/NEJMoa044021 . ISSN   0028-4793. PMID   15668219.
  55. 1 2 Komadina N, McVernon J, Hall R, Leder K (2014). "A historical perspective of influenza A(H1N2) virus". Emerg Infect Dis. 20 (1): 6–12. doi:10.3201/eid2001.121848. PMC   3884707 . PMID   24377419.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  56. ↑ Mahmoud 2005 , p.  7
  57. ↑ "NOVA | scienceNOW | Reviving the Virus (non-Flash) | PBS". www.pbs.org. Retrieved 6 December 2020.
  58. ↑ "Influenza A Virus (H1N2) - an overview". ScienceDirect Topics. Retrieved 21 February 2021.
  59. ↑ Detailed chart of its evolution here Archived 9 May 2009 at the Wayback Machine at PDF called Ecology and Evolution of the Flu
  60. ↑ Mahmoud 2005 , p.  115
    "There is particular pressure to recognize and heed the lessons of past influenza pandemics in the shadow of the worrisome 2003–2004 flu season. An early-onset, severe form of influenza A H3N2 made headlines when it claimed the lives of several children in the United States in late 2003. As a result, stronger than usual demand for annual flu inactivated vaccine outstripped the vaccine supply, of which 10 to 20 percent typically goes unused. Because statistics on pediatric flu deaths had not been collected previously, it is unknown if the 2003–2004 season witnessed a significant change in mortality patterns."
  61. ↑ Reason Archived 26 October 2006 at the Wayback Machine Altman LK (15 January 2006). "This Season's Flu Virus Is Resistant to 2 Standard Drugs". The New York Times .
  62. ↑ CBS News article Dozens in Japan May Have Mild Bird Flu January 2006.
  63. ↑ Ogata T, Yamazaki Y, Okabe N, Nakamura Y, Tashiro M, Nagata N, Itamura S, Yasui Y, Nakashima K, Doi M, Izumi Y, Fujieda T, Yamato S, Kawada Y (July 2008). "Human H5N2 avian influenza infection in Japan and the factors associated with high H5N2-neutralizing antibody titer". Journal of Epidemiology. 18 (4): 160–6. doi:10.2188/jea.JE2007446. PMC   4771585 . PMID   18603824. Archived from the original on 28 September 2018. Retrieved 14 March 2009.
  64. ↑ "Russia reports first human cases of H5N8 bird flu". BNO News. 20 February 2021. Retrieved 20 February 2021.
  65. ↑ "Russia records first cases of human infection with bird flu strain H5N8". Sky News. 20 February 2021. Retrieved 21 February 2021.
  66. ↑ WHO
  67. 1 2 CDC Avian Influenza Infection in Humans
  68. ↑ Tweed SA, Skowronski DM, David ST, Larder A, Petric M, Lees W, Li Y, Katz J, Krajden M, Tellier R, Halpert C, Hirst M, Astell C, Lawrence D, Mak A (December 2004). "Human illness from avian influenza H7N3, British Columbia". Emerging Infectious Diseases. 10 (12): 2196–9. doi:10.3201/eid1012.040961. PMC   3323407 . PMID   15663860.
  69. ↑ Schnirring L (2 April 2013). "China reports 4 more H7N9 infections". CIDRAP News. Archived from the original on 17 May 2013. Retrieved 10 April 2013.
  70. ↑ "Avian Influenza A (H7N9) Virus | Avian Influenza (Flu)". www.cdc.gov. Retrieved 24 February 2017.
  71. ↑ niaid.nih.gov Archived 26 December 2005 at the Wayback Machine Timeline of Human Flu Pandemics
  72. ↑ "China reports first human case of H10N3 bird flu". Reuters. 1 June 2021. Retrieved 22 June 2021.
  73. ↑ Taubenberger JK, Morens DM (January 2006). "1918 Influenza: the mother of all pandemics". Emerging Infectious Diseases. 12 (1): 15–22. doi:10.3201/eid1201.050979. PMC   3291398 . PMID   16494711.
  74. ↑ Science Daily article New Study Has Important Implications For Flu Surveillance published 27 October 2006
  75. ↑ Nelson MI, Simonsen L, Viboud C, Miller MA, Taylor J, George KS, Griesemer SB, Ghedin E, Ghedi E, Sengamalay NA, Spiro DJ, Volkov I, Grenfell BT, Lipman DJ, Taubenberger JK, Holmes EC (December 2006). "Stochastic processes are key determinants of short-term evolution in influenza a virus". PLOS Pathogens. 2 (12): e125. doi: 10.1371/journal.ppat.0020125 . PMC   1665651 . PMID   17140286.
  76. ↑ Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, Osterhaus AD, Fouchier RA (July 2004). "Mapping the antigenic and genetic evolution of influenza virus". Science. 305 (5682): 371–6. Bibcode:2004Sci...305..371S. doi: 10.1126/science.1097211 . PMID   15218094. S2CID   1258353.
  77. ↑ Mahmoud 2005 , p.  30
  78. ↑ Mahmoud 2005 , p.  82
    "Interestingly, recombinant influenza viruses containing the 1918 HA and NA and up to three additional genes derived from the 1918 virus (the other genes being derived from the A/WSN/33 virus) were all highly virulent in mice (Tumpey et al., 2004). Furthermore, expression microarray analysis performed on whole lung tissue of mice infected with the 1918 HA/ NA recombinant showed increased upregulation of genes involved in apoptosis, tissue injury, and oxidative damage (Kash et al., 2004). These findings were unusual because the viruses with the 1918 genes had not been adapted to mice. The completion of the sequence of the entire genome of the 1918 virus and the reconstruction and characterization of viruses with 1918 genes under appropriate biosafety conditions will shed more light on these findings and should allow a definitive examination of this explanation. Antigenic analysis of recombinant viruses possessing the 1918 HA and NA by hemagglutination inhibition tests using ferret and chicken antisera suggested a close relationship with the A/swine/Iowa/30 virus and H1N1 viruses isolated in the 1930s (Tumpey et al., 2004), further supporting data of Shope from the 1930s (Shope, 1936). Interestingly, when mice were immunized with different H1N1 virus strains, challenge studies using the 1918-like viruses revealed partial protection by this treatment, suggesting that current[ when? ] vaccination strategies are adequate against a 1918-like virus (Tumpey et al., 2004)."
  79. ↑ "Avian influenza A(H5N1)- update 31: Situation (poultry) in Asia: need for a long-term response, comparison with previous outbreaks". Epidemic and Pandemic Alert and Response (EPR). WHO. 2004. Archived from the original on 7 March 2004.
    Known outbreaks of highly pathogenic flu in poultry 1959–2003.
  80. ↑ Geraci JR, St Aubin DJ, Barker IK, Webster RG, Hinshaw VS, Bean WJ, Ruhnke HL, Prescott JH, Early G, Baker AS, Madoff S, Schooley RT (February 1982). "Mass mortality of harbor seals: pneumonia associated with influenza A virus". Science. 215 (4536): 1129–31. Bibcode:1982Sci...215.1129G. doi:10.1126/science.7063847. PMID   7063847. More than 400 harbor seals, most of them immature, died along the New England coast between December 1979 and October 1980 of acute pneumonia associated with influenza virus, A/Seal/Mass/1/180 (H7N7). The virus has avian characteristics, replicates principally in mammals, and causes mild respiratory disease in experimentally infected seals. Concurrent infection with a previously undescribed mycoplasma or adverse environmental conditions may have triggered the epizootic. The similarities between this epizootic and other seal mortalities in the past suggest that these events may be linked by common biological and environmental factors.
  81. 1 2 CDC Centers for Disease Control and Prevention – Transmission of Influenza A Viruses Between Animals and People
  82. ↑ Kandeil A, Gomaa MR, Shehata MM, El Taweel AN, Mahmoud SH, Bagato O (January 2019). "Isolation and Characterization of a Distinct Influenza A Virus from Egyptian Bats". Journal of Virology. 93 (2): e01059-18. doi:10.1128/JVI.01059-18. PMC   6321940 . PMID   30381492.
  83. ↑ Ciminski K, Ran W, Gorka M, Lee J, Schinköthe J, Eckley M, Murrieta MA, Aboellail TA, Campbell CL, Ebel GD, Ma J, Pohlmann A, Franzke K, Ulrich R, Hoffmann D, Garcia-Sastre A, Ma W, Schountz T, Beer M, Schwemmle M (2019). "Bat influenza viruses transmit among bats but are poorly adapted to non-bat species". Nature Microbiology. 4 (12): 2298–2309. doi:10.1038/s41564-019-0556-9. PMC   7758811 . PMID   31527796. S2CID   202580293.

Further reading

Official sources
General information
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.